Skip to main content
Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
1,008.39
+18.06 (1.82%)
At close: Mar 9, 2026, 4:00 PM EDT
1,002.77
-5.62 (-0.56%)
After-hours: Mar 9, 2026, 7:59 PM EDT

Eli Lilly Revenue

In the year 2025, Eli Lilly had annual revenue of $65.18B with 44.70% growth. Eli Lilly had revenue of $19.29B in the quarter ending December 31, 2025, with 42.55% growth.

Revenue (ttm)
$65.18B
Revenue Growth
+44.70%
P/S Ratio
13.82
Revenue / Employee
$1,303,580
Employees
50,000
Market Cap
900.85B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202565.18B20.14B44.70%
Dec 31, 202445.04B10.92B32.00%
Dec 31, 202334.12B5.58B19.56%
Dec 31, 202228.54B223.00M0.79%
Dec 31, 202128.32B3.78B15.40%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Johnson & Johnson 94.19B
Merck & Co. 65.01B
Pfizer 62.58B
AbbVie 61.16B
AstraZeneca 58.74B
Novartis AG 56.67B
Novo Nordisk 48.59B
Bristol-Myers Squibb Company 48.19B
Revenue Rankings

LLY News

More News